| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |